Certification is possible provided that
Acceptable DOACs are Dabigatran, Rivaroxaban and Apixaban.
Likely indications include:
Prior to certification, for pilots taking warfarin the INR should be demonstrated to be within the target range for 6 months (4 results at 2 monthly intervals) and 2 monthly laboratory testing should be continued on an ongoing basis. If the INR varies considerably within the target range on the initial readings, a longer period of surveillance may be required. Pilots taking DOACs should be free of side effects for a period of 3 months prior to fitness reassessment.
Class 1 applicants treated with warfarin are required to measure their INR on a ‘near patient’ testing system (such as CoaguChek S) 12 hours prior to flight and only fly if the INR is within the target range. The INR should be recorded in the Log Book. The Log Book should be reviewed at each medical certificate revalidation examination.
For LAPL pilots, a shorter period of stabilisation (6 weeks for DOACs and 4 months for warfarin) may be acceptable provided there are no side effects and there is reliable evidence of INR stability in pilots taking warfarin.
We are currently recruiting an Infrastructure Analyst for our Gatwick-based IT team. If you have think you have the… https://t.co/E8WsLAzuGY
13 hours ago
Making it easier for those with hidden disabilities to fly - new guidance for airlines published today:… https://t.co/IvvmUbRu0U
2 days ago
We are currently recruiting an airworthiness surveyor for our General Aviation Unit. If you have the right qualific… https://t.co/nXcX9pT10o
2 days ago
Read all @UK_CAA
Airlines given guidance on assisting passengers with hidden disabilities
15 October, 2018
Hueys get risk approval for paid flights
5 October, 2018
Further advice to UK consumers impacted by Primera Air ceasing operations
2 October, 2018
Read all News
Tackling crime and improving safety
4 October, 2018
More flights and fuller aircraft as UK air traffic continues to grow
27 July, 2018
Sharing the cost of recreational flying
4 May, 2018
Read All Blogs